PT1011696E - Tratamento do stresse e precondicoes contra o stresse - Google Patents

Tratamento do stresse e precondicoes contra o stresse

Info

Publication number
PT1011696E
PT1011696E PT98943592T PT98943592T PT1011696E PT 1011696 E PT1011696 E PT 1011696E PT 98943592 T PT98943592 T PT 98943592T PT 98943592 T PT98943592 T PT 98943592T PT 1011696 E PT1011696 E PT 1011696E
Authority
PT
Portugal
Prior art keywords
radiation
ozone
mild heating
stress
oxygen gas
Prior art date
Application number
PT98943592T
Other languages
English (en)
Inventor
Pavel Hamet
Johanne Tremblay
Original Assignee
Vasogen Ireland Ltd
Ct Rech Ct Hospitalier L Unive
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from CA 2218625 external-priority patent/CA2218625A1/en
Priority claimed from CA 2230836 external-priority patent/CA2230836A1/en
Application filed by Vasogen Ireland Ltd, Ct Rech Ct Hospitalier L Unive filed Critical Vasogen Ireland Ltd
Publication of PT1011696E publication Critical patent/PT1011696E/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/14—Blood; Artificial blood
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/40—Peroxides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
    • A61K41/0004—Homeopathy; Vitalisation; Resonance; Dynamisation, e.g. esoteric applications; Oxygenation of blood
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
    • A61M1/14—Dialysis systems; Artificial kidneys; Blood oxygenators ; Reciprocating systems for treatment of body fluids, e.g. single needle systems for hemofiltration or pheresis
    • A61M1/32—Oxygenators without membranes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
    • A61M1/36—Other treatment of blood in a by-pass of the natural circulatory system, e.g. temperature adaptation, irradiation ; Extra-corporeal blood circuits
    • A61M1/3681—Other treatment of blood in a by-pass of the natural circulatory system, e.g. temperature adaptation, irradiation ; Extra-corporeal blood circuits by irradiation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
    • A61M1/36—Other treatment of blood in a by-pass of the natural circulatory system, e.g. temperature adaptation, irradiation ; Extra-corporeal blood circuits
    • A61M1/3681—Other treatment of blood in a by-pass of the natural circulatory system, e.g. temperature adaptation, irradiation ; Extra-corporeal blood circuits by irradiation
    • A61M1/3683—Other treatment of blood in a by-pass of the natural circulatory system, e.g. temperature adaptation, irradiation ; Extra-corporeal blood circuits by irradiation using photoactive agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
    • A61M1/36—Other treatment of blood in a by-pass of the natural circulatory system, e.g. temperature adaptation, irradiation ; Extra-corporeal blood circuits
    • A61M1/369—Temperature treatment
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/02—Non-specific cardiovascular stimulants, e.g. drugs for syncope, antihypotensives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2205/00—General characteristics of the apparatus
    • A61M2205/05—General characteristics of the apparatus combined with other kinds of therapy
    • A61M2205/051—General characteristics of the apparatus combined with other kinds of therapy with radiation therapy
    • A61M2205/053—General characteristics of the apparatus combined with other kinds of therapy with radiation therapy ultraviolet

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Vascular Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Hematology (AREA)
  • Cardiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Anesthesiology (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Emergency Medicine (AREA)
  • Biotechnology (AREA)
  • Cell Biology (AREA)
  • Virology (AREA)
  • Urology & Nephrology (AREA)
  • Immunology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Inorganic Chemistry (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Physical Or Chemical Processes And Apparatus (AREA)
  • Magnetic Heads (AREA)
  • Dental Preparations (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
PT98943592T 1997-09-12 1998-09-11 Tratamento do stresse e precondicoes contra o stresse PT1011696E (pt)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US5878297P 1997-09-12 1997-09-12
US5917297P 1997-09-17 1997-09-17
CA 2218625 CA2218625A1 (en) 1997-09-12 1997-10-20 Stress treatment and preconditioning against stress
CA 2230836 CA2230836A1 (en) 1998-02-27 1998-02-27 Inducing resistance to ischemic stresses

Publications (1)

Publication Number Publication Date
PT1011696E true PT1011696E (pt) 2004-03-31

Family

ID=27427399

Family Applications (1)

Application Number Title Priority Date Filing Date
PT98943592T PT1011696E (pt) 1997-09-12 1998-09-11 Tratamento do stresse e precondicoes contra o stresse

Country Status (13)

Country Link
EP (1) EP1011696B1 (pt)
JP (1) JP4141636B2 (pt)
AT (1) ATE253922T1 (pt)
AU (1) AU741181B2 (pt)
DE (1) DE69819749T2 (pt)
DK (1) DK1011696T3 (pt)
EA (1) EA003232B1 (pt)
ES (1) ES2210814T3 (pt)
HK (1) HK1031322A1 (pt)
IL (3) IL135018A0 (pt)
NZ (1) NZ503770A (pt)
PT (1) PT1011696E (pt)
WO (1) WO1999013890A1 (pt)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK1146885T3 (da) * 1999-01-12 2003-09-22 Ct De Rech Du Ct Hospitalier D Forbehandling mod celledød
US7045124B1 (en) 1999-01-12 2006-05-16 Vasogen Irelend Limited Pre-conditioning against cell death
CA2271190A1 (en) * 1999-05-06 2000-11-06 Vasogen Ireland Limited Improved method for treating mammals with modified mammalian blood
ATE263540T1 (de) * 1999-09-16 2004-04-15 Vasogen Ireland Ltd Vorrichtung zum beeinflussen des blutes eines säugetieres
US7125897B1 (en) 1999-09-24 2006-10-24 Vasogen Ireland Limited Combined therapies for atherosclerosis treatment
CA2296997A1 (en) * 2000-01-18 2001-07-18 Vasogen Ireland Limited Treatment of congestive heart failure
EP1427394B1 (en) * 2001-09-18 2007-03-14 Vasogen Ireland Limited Process for accelerating recovery from trauma by using apoptosis-mimicking synthetic or natural entities

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5591457A (en) * 1992-02-07 1997-01-07 Vasogen Inc Method of inhibiting the aggregation of blood platelets and stimulating the immune systems of a human
US5980954A (en) * 1992-02-07 1999-11-09 Vasogen Ireland Limited Treatment of autoimmune diseases
AU681999B2 (en) * 1992-02-07 1997-09-18 Vasogen Ireland Limited Method of increasing the concentration of nitric oxide in blood
JPH08652A (ja) * 1994-06-24 1996-01-09 Oskar:Kk 男性機能回復補助器具
DK0768886T3 (da) * 1995-05-05 2003-12-01 Vasogen Ireland Ltd Endothelforingseffekter og behandling af vasospastiske lidelser
JPH09227394A (ja) * 1995-12-22 1997-09-02 Taisho Pharmaceut Co Ltd 経口投与用組成物

Also Published As

Publication number Publication date
ATE253922T1 (de) 2003-11-15
IL135018A (en) 2006-06-11
EA200000312A1 (ru) 2001-04-23
IL135014A0 (en) 2001-05-20
DK1011696T3 (da) 2004-03-15
EP1011696A1 (en) 2000-06-28
JP4141636B2 (ja) 2008-08-27
WO1999013890A1 (en) 1999-03-25
AU9148098A (en) 1999-04-05
HK1031322A1 (en) 2001-06-15
EA003232B1 (ru) 2003-02-27
NZ503770A (en) 2002-10-25
JP2001516723A (ja) 2001-10-02
IL135018A0 (en) 2001-05-20
AU741181B2 (en) 2001-11-22
ES2210814T3 (es) 2004-07-01
EP1011696B1 (en) 2003-11-12
DE69819749D1 (de) 2003-12-18
DE69819749T2 (de) 2004-09-30

Similar Documents

Publication Publication Date Title
BG101284A (en) Compounds and methods for cancer treatment
UA32429C2 (uk) Засіб для лікування нетримання сечі
CY1111782T1 (el) Μεθοδος για βιομηχανικη θεραπεια μεσω κυματων
MX9300607A (es) Aparato y metodo para tratamiento intersticial.
AU5710794A (en) Medical appliance for intermittent compression treatment
BR9405763A (pt) Processo para tratar fluido corpóreo processo para tratar produto de sangue e processo para fornecer produtos de sangue a paciente
BR0309890A (pt) Composição farmacêutica contendo plasma sanguìneo, ou soro sanguìneo utilizada no tratamento de lesões, bem como seu método e processo de aplicação
NO20013004L (no) Anvendelse av biokjemiske substanser i en sammensetning for forhindringen og behandlingen av helsetilstander forårsaket avkonstriksjon av glattmuskelceller i organer i det menneskeligelegemet
ES2179096T3 (es) Utilizacion de la interleucina-12 para prevenir la reaccion del injerto contra el huesped.
DE3788231D1 (de) Kosmetisches mittel und zusammensetzung zur behandlung der haut.
PT1011696E (pt) Tratamento do stresse e precondicoes contra o stresse
BR9912773A (pt) Processo e aparelho para o tratamento tópico de tecido doente e processo para o tratamento de doenças em vasos do sistema circulatório
MY120530A (en) Combination preparation for use in dementia
MX9307667A (es) Metodo de tratamiento termico rapido para fibra de polibenzazol.
DE60103658D1 (de) Ex-vivo unter oxidativen stress behandelte cll-zellen zur behandlung chronischer lymphozytärer läukemie (cll)
FR2891140B1 (fr) Procede de traitement des fibres keratiniques par application d'un melange eau liquide/vapeur d'eau
ES2046944B1 (es) Procedimiento para la destruccion de microorganismos y enzimas mediante la aplicacion combinada de calor y ultrasonidos bajo presion: proceso mts (mano-termo-sonicacion).
Kim et al. The effectiveness of bee venom acupuncture therapy on the treatment of sprain of l-spine (a randomized controlled trial; double blinding)
AU1275400A (en) Method and apparatus for treating contaminated waste
NO985906D0 (no) Vegetabilsk ekstrakt, fremgangsmÕte ved fremstilling derav og dets anvendelse i human- og veteringµrmedisin
UA32241A (uk) Спосіб лікування запалювальних процесів у експериментальних тварин
UA7955A (uk) Спосіб лікування туберкульозу легенів
DE69509318D1 (de) Hyperbarische Druckkammer für medizinische Hochdruck Behandlung mit keinen strukturellen Hindernissen
NO20014180L (no) Anvendelse av fluorinerte triazoler til behandling av smerte og smertefulle lidelser eller oppmerksomhetshunger
EA199800818A1 (ru) Способ лечения бессонницы